Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pfizer
Woman and Man Max 99 years
Pfizer Pharma GmbH
Update Il y a 4 ans
Somatropin Therapy for Short Children Born of Premature Gestation: A Controlled, Prospective Randomized, Multicenter Study with an Untreated Control Group
To determine whether growth hormone therapy improves growth velocity and height SDS after one year in (very low birth weight (VLBW) preterm infants born appropriate-for-gestational age (AGA) with shor...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer OpenAir
Update Il y a 4 ans
Non Invasive Ventilation in COPD: Predicting outcome in hospital and assessing quality of life over one year
Background and study aims Chronic obstructive pulmonary disease (COPD) is the name given to a collection of diseases which affect the lungs. It is characterised by breathlessness, cough and excess muc...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Pfizer Inc, 235 East 42nd Street, New York, New York 10017
Update Il y a 4 ans
A multi-center, open-label study of CP-690,550 in subjects with moderate to severe ulcerative colitis
To assess the safety and tolerability of long-term tofacitinib therapy in subjects with UC.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pfizer Italia S.p.A. (Italy) - supplied study drugs, provided financial support with a grant, but was not involved in the concept, design, enrolment, data collection, analysis and interpretation of its results
Update Il y a 4 ans
Prophylactic fluconazole is effective in preventing fungal colonisation and infection in preterm neonates: a multicentre, randomised trial in Italy
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc. 235 East 42nd Street, NEW YORK, NY 10017. US
Update Il y a 4 ans
Study safety and effectiveness of a reduce to quit approach using varenicline versus placebo
The primary objective is to compare the efficacy of varenicline to placebo for smoking cessation during the last 10 weeks of treatment in subjects who are not willing/able to make an abrupt quit attem...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc., 235 East 42nd Street, New York, NY 10017, United states
Update Il y a 4 ans
A 15 MONTH, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED PHASE 3 STUDY TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF CP 945,598 IN PREVENTION OF WEIGHT REGAIN IN OBESE SUBJECTS
• To examine the long term efficacy of CP 945,598 in prevention of weight regain in obese or overweight subjects over 12 months after previous weight loss (WL)induced by an 8 week low calorie diet (LC...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
A RANDOMISED, DOUBLE-BLIND (SPONSOR-OPEN), PLACEBO-CONTROLLED, MULTICENTRE STUDY IN ASYMPTOMATIC HIV-INFECTED PATIENTS TO INVESTIGATE THE PHARMACODYNAMICS, PHARMACOKINETICS, SAFETY AND TOLERATION OF PF-00232798
- Investigate the effects of 10-day monotherapy of PF-00232798 on viral load response in asymptomatic HIV-infected patients and to the assess dose-response relationship. - Assess the pharmacokinetics,...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Pfizer
Update Il y a 4 ans
Pfizer A4061032 AXIS : Essai de phase 3 randomisé comparant l’efficacité de l’axitinib au sorafénib, en traitement de 2ème ligne, chez des patients ayant un cancer du rein métastatique. [essai clos aux inclusions]
L’objectif de cet essai est de comparer l’efficacité de l’axitinib et du sorafénib chez des patients ayant un cancer du rein métastatique. Les patients seront répartis de façon aléatoire en 2 groupes...
Country
France
organs
Rein
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Man Max 99 years
Pfizer, S. A
Update Il y a 4 ans
A multicenter, double-blind placebo controlled, fixed dose study with an open-label, flexible dose phase to assess the efficacy of Sildenafil Citrate in providing a better sexual experience including quality of erections and satisfaction in men with erectile dysfunction
To evaluate the effect of sildenafil citrate versus placebo on the IIEF-EF Domain at the end of the double-blind phase.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
A study in young adults to see if 3 doses of Mn B vaccine works
Primary Objectives To assess the immune response as measured by serum bactericidal assay using human complement (hSBA) performed with 4 primary MnB test strains, two expressing a LP2086 subfamily A...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
2
3
4
5
6
7
8
9
10
11
Next